2'-fluorothymidine has been researched along with pnu183792 in 1 studies
| Studies (2'-fluorothymidine) | Trials (2'-fluorothymidine) | Recent Studies (post-2010) (2'-fluorothymidine) | Studies (pnu183792) | Trials (pnu183792) | Recent Studies (post-2010) (pnu183792) |
|---|---|---|---|---|---|
| 187 | 18 | 39 | 7 | 0 | 1 |
| Protein | Taxonomy | 2'-fluorothymidine (IC50) | pnu183792 (IC50) |
|---|---|---|---|
| DNA polymerase catalytic subunit | Human alphaherpesvirus 1 strain 17 | 0.6 | |
| DNA polymerase catalytic subunit | Human herpesvirus 5 strain AD169 | 0.7 | |
| DNA polymerase catalytic subunit | Human herpesvirus 3 strain Dumas | 0.37 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morio, T | 1 |
1 review(s) available for 2'-fluorothymidine and pnu183792
| Article | Year |
|---|---|
[Therapeutic approach to EBV infection].
Topics: Antimicrobial Cationic Peptides; Antiviral Agents; Arabinofuranosyluracil; Benzimidazoles; Drug Design; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Hydroxyurea; Immunotherapy; Quinolines; Ribonucleosides; RNA, Small Interfering | 2006 |